# Corticosteroid Therapy in Refractory Shock Following Cardiac Arrest

> **NCT00676585** · PHASE1,PHASE2 · COMPLETED · sponsor: **Beth Israel Deaconess Medical Center** · enrollment: 50 (actual)

## Conditions studied

- Cardiac Arrest

## Interventions

- **DRUG:** Normal Saline
- **DRUG:** Hydrocortisone

## Key facts

- **NCT ID:** NCT00676585
- **Lead sponsor:** Beth Israel Deaconess Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-10
- **Primary completion:** 2014-04
- **Final completion:** 2014-04
- **Target enrollment:** 50 (ACTUAL)
- **Last updated:** 2017-05-17

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00676585

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00676585, "Corticosteroid Therapy in Refractory Shock Following Cardiac Arrest". Retrieved via AI Analytics 2026-09-28 from https://api.ai-analytics.org/clinical/NCT00676585. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*